SDGR - Schrodinger Inc logo

SDGR

Schrodinger Inc

Schrödinger Inc develops computational platforms for drug discovery and materials applications, providing software solutions for life sciences and materials science. Its Drug Discovery segment advances preclinical and clinical programs through collaborations.

⚕️ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago $314today

Score Overview

1 Year
Score
Net Growth47.38%
Net TrendGrew
Net Income Consistency
Rev Growth1.24%
Rev TrendGrew
Revenue Consistency
5 Years
Score6.0
Net Growth45.88%
Net Trend60%
Net Income Consistency
Rev Growth87.80%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth-122.11%
Net Trend50%
Net Income Consistency
Rev Growth139.64%
Rev Trend83%
Revenue Consistency

See the full market ranking →

Schrodinger Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 108M to $ 255M and net income went from -$ 24M to -$ 103M. Revenue increased in 4 of those 5 years; net income in 3.

Schrodinger Inc currently holds a 5-year HDB Score of 6.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 18.63
1 Year2025-08-12
$ 18.85-1.17%
5 Years2021-08-12
$ 59.37-68.62%
All Time2020-02-06
$ 28.64-34.95%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 259M-$ 54M$ 413M
2025$ 255M-$ 103M$ 395M
2024$ 207M-$ 187M$ 352M
2023$ 216M$ 40M$ 463M
2022$ 180M-$ 149M$ 451M
2021$ 137M-$ 100M$ 576M
IPO2020$ 108M-$ 24M$ 642M

Explore beyond SDGR

You're looking at Schrodinger Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies